Sugammadex and Decreased Time to Extubation

NCT03196167 PHASE4 COMPLETED Results posted

The purpose of this study is to demonstrate faster time to extubation after arrival in the cardiothoracic intensive care unit (ICU) in patients undergoing isolated coronary artery bypass grafting (CABG), AVR and AVR/CABG combination who receive Sugammadex as compared to placebo.

Details

Lead sponsor	Yale University
Phase	PHASE4
Status	COMPLETED
Enrolment	90
Start date	Sat May 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sat Oct 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Coronary Artery Bypass Graft and/or Aortic Valve Replacement Surgery

Interventions

• Sugammadex
• Placebo

Countries

United States